317490006: Ispaghula husk 56% powder 6.4g (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

461898017 Ispaghula husk 56% powder 6.4g en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

1188110017 Ispaghula husk 56% powder 6.4g (product) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core

461898017 Ispaghula husk 56% powder 6.4g en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

714264011 Ispaghula husk 56% powder 6.4g (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1188110017 Ispaghula husk 56% powder 6.4g (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1188110017 Ispaghula husk 56% powder 6.4g (product) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ispaghula husk 56% powder 6.4g	Is a	Ispaghula husk powder	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ispaghula husk 56% powder 6.4g	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Ispaghula husk (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ispaghula husk 56% powder 6.4g	Has manufactured dose form	Conventional release oral powder (dose form)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Ispaghula husk 56% powder 6.4g	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Antilipemic agent (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator attribute value reference set (foundation metadata concept)